Merck (MRK) Exchange Rate Effect (2009 - 2026)

Merck (MRK) posted quarterly Exchange Rate Effect of -$19.0 million for Q1 2026, down 112.18% YoY from $156.0 million in Q1 2025, and down 182.61% sequentially from $23.0 million in Q4 2025.

Merck (MRK) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Merck has disclosed Exchange Rate Effect across 18 years of filings, most recently posting -$19.0 million for Q1 2026.

  • In Q1 2026, Exchange Rate Effect fell 112.18% year-over-year to -$19.0 million; the TTM figure through Mar 2026 stood at $388.0 million (up 38700.0% YoY), while the FY2025 annual figure was $563.0 million, up 292.15% from the prior year.
  • Exchange Rate Effect fell to -$19.0 million in Q1 2026, from $23.0 million in the prior quarter.
  • Over the last five years, Exchange Rate Effect for MRK reached as high as $374.0 million in Q2 2025 and fell as low as -$412.0 million in Q3 2022.
  • The 5-year median for Exchange Rate Effect is -$19.0 million (2026), against an average of -$8.0 million.
  • The widest YoY moves for Exchange Rate Effect: up 638.24% in 2022, down 795.65% in 2022.
  • A 5-year view of Exchange Rate Effect shows it stood at $366.0 million in 2022, then plunged by 49.18% to $186.0 million in 2023, then plunged by 297.31% to -$367.0 million in 2024, then jumped by 106.27% to $23.0 million in 2025, then slumped by 182.61% to -$19.0 million in 2026.
  • According to Business Quant data, Exchange Rate Effect over the past three periods registered -$19.0 million, $23.0 million, and $10.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FX Effect (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 67.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -25.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -12.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -18.00 Mn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -19.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -11.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 19.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -77.00 Mn
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -18.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -19.00 Mn
Mar 31, 2026 -19.00 Mn
Dec 31, 2025 23.00 Mn
Dec 31, 2025 23.00 Mn
Sep 30, 2025 10.00 Mn
Sep 30, 2025 10.00 Mn
Jun 30, 2025 374.00 Mn
Jun 30, 2025 374.00 Mn
Mar 31, 2025 156.00 Mn
Mar 31, 2025 156.00 Mn
Dec 31, 2024 -367.00 Mn
Dec 31, 2024 -367.00 Mn
Sep 30, 2024 294.00 Mn
Sep 30, 2024 294.00 Mn
Jun 30, 2024 -82.00 Mn
Jun 30, 2024 -82.00 Mn
Mar 31, 2024 -138.00 Mn
Mar 31, 2024 -138.00 Mn
Dec 31, 2023 186.00 Mn
Dec 31, 2023 186.00 Mn